Faye Rogers named associate cancer center director for DEI at Yale

A post-treatment blood test could inform future cancer therapy decisions, study shows

In the continuing evolution of personalized medicine, a new Yale study has found evidence to support the value of a tool that measures the presence of cancer-derived molecules in the blood of patients with lung cancer years after their treatment.

March 21, 2025

Vol.51 No.11

In Brief

William Oh named service medical director at Smilow Cancer Hospital at Greenwich

William K. Oh was appointed as service medical director of Smilow Cancer Hospital at Greenwich Hospital, as well as director of precision medicine for Yale Cancer Center and Smilow Cancer Hospital.

November 22, 2024

Vol.50 No.44

Cancer History Project

Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician

A mathematical puzzle fascinated Susan Ellenberg as a child.

October 25, 2024

Vol.50 No.40

By McKenzie Prillaman

Cancer History Project

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Hispanic and Latino people comprise nearly 20% of the U.S. population, but less than 6% of physicians nationwide identify as Hispanic.

October 11, 2024

Vol.50 No.38

By Ruben A. Mesa and McKenzie Prillaman

Conversation with The Cancer Letter

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Every summer since 2010, ten undergraduate students from diverse backgrounds get the opportunity to explore any curiosities they might have about careers in medicine at Memorial Sloan Kettering Cancer Center.

October 04, 2024

Vol.50 No.37

By Claire Marie Porter

Clinical Roundup

Barcode technology could help diagnose cancer more precisely

A pathology tool created at Yale harnesses barcode technology and shows potential for use in cancer diagnoses. The technology, Patho-DBiT (pathology-compatible deterministic barcoding in tissue), was discussed in a study published Sept. 30 in the journal Cell.

October 04, 2024

Vol.50 No.37

Faye Rogers named associate cancer center director for DEI at Yale

YOU MAY BE INTERESTED IN

A post-treatment blood test could inform future cancer therapy decisions, study shows

William Oh named service medical director at Smilow Cancer Hospital at Greenwich

Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Barcode technology could help diagnose cancer more precisely

Renew today!

Subscriber content

Faye Rogers named associate cancer center director for DEI at Yale

YOU MAY BE INTERESTED IN

A post-treatment blood test could inform future cancer therapy decisions, study shows

William Oh named service medical director at Smilow Cancer Hospital at Greenwich

Susan Ellenberg started out as a high school math teacher—then became a leading biostatistician

Latino oncology leaders discuss representation in clinical trials, translational research, and health careMesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”

Undergrad intern at MSK poses a profound question: What if Henrietta Lacks had a Black doctor?

Barcode technology could help diagnose cancer more precisely

Latino oncology leaders discuss representation in clinical trials, translational research, and health care
Mesa, Carvajal-Carmona, Cruz-Correa, Perez, Ramirez, Sanchez: “We’re here to help lead and collaborate.”